Callan JMB Inc. Reports Q1 2025 Results with $1.2 Million Net Loss and 42.5% Gross Profit Margin After IPO Completion

Reuters
05-16
<a href="https://laohu8.com/S/CJMB">Callan JMB Inc.</a> Reports Q1 2025 Results with $1.2 Million Net Loss and 42.5% Gross Profit Margin After IPO Completion

Callan JMB Inc., an integrative logistics company in the healthcare and emergency management sectors, released its financial results for the first quarter ending March 31, 2025. The company reported a cost of revenue of $0.8 million and achieved a gross profit of $0.6 million with a gross profit margin of 42.5%. SG&A expenses increased to $1.9 million, driven by consulting and professional fees related to the company's IPO and the addition of its CEO and other senior staff to payroll. Callan JMB reported an operating loss of $1.2 million and a net loss of $1.2 million for the quarter. The company recently completed its IPO on February 6, 2025, at $4.00 per share, raising gross proceeds of approximately $5.7 million. Callan JMB is actively expanding its emergency preparedness and response operations to untapped metropolitan areas and states. The appointment of Christopher Shields as Senior Vice President of Emergency Preparedness & Response/Government Affairs is expected to accelerate this expansion. The company is also pursuing growth opportunities in rapidly expanding markets, including GLP-1 pharmaceutical transportation, specialized compounding pharmacy logistics, and premium food packaging services.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Callan JMB Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-011058), on May 15, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10